Genus (LON:GNS) Releases Quarterly Earnings Results

Genus (LON:GNS) issued its quarterly earnings data on Thursday. The company reported GBX 110.30 earnings per share for the quarter, Digital Look Earnings reports. Genus had a return on equity of 9.70% and a net margin of 7.07%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Stock Performance

LON GNS traded up GBX 32 on Friday, reaching GBX 2,192. The stock had a trading volume of 3,602,064 shares, compared to its average volume of 785,822. The company has a market cap of £1.46 billion, a P/E ratio of 30.87, a price-to-earnings-growth ratio of 2.87 and a beta of 0.90. The company has a debt-to-equity ratio of 51.73, a current ratio of 2.25 and a quick ratio of 1.08. The firm has a fifty day moving average of GBX 2,222.27 and a two-hundred day moving average of GBX 2,375.37. Genus has a 1-year low of GBX 1,943 and a 1-year high of GBX 3,220.

Insider Buying and Selling at Genus

In other Genus news, insider Celia Baxter acquired 2,336 shares of the stock in a transaction dated Friday, June 26th. The stock was purchased at an average cost of GBX 2,140 per share, with a total value of £49,990.40. Company insiders own 0.71% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 3,350 target price on shares of Genus in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of GBX 3,216.67.

Trending Headlines about Genus

Here are the key news stories impacting Genus this week:

• Positive Sentiment: Genus launched a £60 million share buyback, signaling management’s confidence in the company’s long-term growth prospects and potentially supporting earnings per share. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: FY26 pretax profit increased, while leverage declined following developments involving the company’s China joint venture. The improved balance sheet and profitability provide some support for the shares. Genus FY26 Pretax Profit Rises
• Positive Sentiment: Berenberg reaffirmed its “buy” rating and set a GBX 3,350 price target, implying substantial upside from recent trading levels. Berenberg rating update
• Neutral Sentiment: Genus reported quarterly earnings of GBX 110.30 per share, with a 9.70% return on equity and a 7.07% net margin. These figures offer evidence of ongoing profitability but did not outweigh concerns about the outlook.
• Negative Sentiment: The company forecast only moderate operating-profit growth for FY27, disappointing investors seeking stronger near-term expansion. Genus Shares Fall 7% as Company Forecasts Moderate FY27 Operating Profit Growth
• Negative Sentiment: FY26 revenue missed expectations, which overshadowed the rise in profits and triggered selling pressure. The resulting share-price weakness reflects concerns over demand, growth momentum and valuation. Genus announces £60m buyback as FY profits rise but shares drop on revenue miss

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.